Advanced Search

All Active Funding Opportunities

For questions regarding these opportunities, please contact Sarah Laye at: slaye@som.umaryland.edu.

Date Posted Organization Title Website Type LOI and/or Application Due Date Comments / Documents
07/26/18 NIH Integration of Individual Residential Histories into Cancer Research (R21) Link NIH Standard dates apply
04/01/22 NIH Focused Technology Research and Development (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply Next application deadline is 6/5/22.
06/10/20 NIH Cancer Prevention, Diagnosis, and Treatment Technologies for Low-Resource Settings (R43/R44 - Clinical Trial Optional) Link NIH Standard due dates apply - note new SBIR/STTR Standard Due Dates. LOI required and due 30 days prior to the application due date.
11/09/18 NIH National Cancer Institute Youth Enjoy Science Research Education Program (R25) Link NIH Standard dates apply LOI due 30 days prior to the application due date
07/22/22 NIH HEAL Initiative Notice of Special Interest (NOSI): Development and Validation of Pain-Related Models and Endpoints to Facilitate Non-Addictive Analgesic Discovery Link NIH NOSI Application due: 06/25/25 Expiration Date: June 25, 2025
07/22/22 NIH Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed) Link NIH Standard due dates apply
11/21/18 NIH Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01) Link NIH Standard due dates apply Moonshot
11/27/19 NIH The NCI Transition Career Development Award (K22 Independent Clinical Trial Required) Link NIH Standard due dates apply
07/19/18 NIH Mechanisms of Cancer and Treatment-related Symptoms and Toxicities (R21) Link NIH Standard dates apply
05/29/20 NIH Cancer Research Education Grants Program - Research Experiences (R25) Link NIH Standard dates apply
06/10/20 NIH Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Link NIH Due dates vary by awarding IC
11/21/18 NIH Dissemination and Implementation Research in Health (R01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days prior to the application due date
01/24/23 NIH Notice of Special Interest (NOSI): Research on the Etiology, Early Detection, Screening and Prevention of Early-Onset Colorectal Cancer Link NIH NOSI Application due: 09/08/24
11/08/20 NIH Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30) Link NIH Standard due dates apply
12/13/23 NIAID Notice of Special Interest (NOSI): Development of Organotypic Culture Models for Transplantation Immunology Research Link NIH NOSI Application due: 11/17/26
10/21/22 NCI, NHGRI, NIDCR Secondary Analysis and Integration of Existing Data to Elucidate the Genetic Architecture of Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
09/18/20 NCI NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 No Independent Clinical Trials) Link NIH Standard due dates apply
09/10/21 NCI Basic Research in Cancer Health Disparities (R03 Clinical Trial Not Allowed) Link NIH Standard due dates apply Next due date is 10/16/21.
04/10/23 NCI Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed) Link NIH Application due: 06/13/24 LOI due 30 days before application due date
09/15/22 NCI Notice of Special Interest: Administrative Supplements to Participate in the NCI Early-stage Surgeon Scientist Program (ESSP) Link NOSI Expiration Date: 12/9/23
12/13/23 NCI Notice of Intent to Publish a Notice of Funding Opportunity for National Cancer Institute's Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (U54 Clinical Trial Optional) Link NIH NOSI Application due: 09/25/24
01/17/24 NCI Notice of Special Interest (NOSI): Chronic Inflammation of the Oral Cavity - An Agent for Oral Mucosal Disease Link NIH NOSI Application due: 05/10/27
03/31/24 NCI Notice of Special Interest (NOSI): Administrative Supplements for Assessing and Enhancing Survivorship Care Link NIH NOSI Application due: 06/05/24
07/22/22 NCI Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
08/29/23 NCI Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) Link NIH Standard due dates apply
12/13/23 NCI NCI Pathway to Independence Award for Early-Stage Postdoctoral Researchers (K99/R00 - Independent Basic Experimental Studies with Humans Required) Link NIH Application due: 06/14/24
07/08/22 NCI Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors Link NIH NOSI Application due: 10/09/24 First Available Due Date: 3/7/22. Expiration Date: 10/9/24.
08/16/22 NCI Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed) Link NIH Application due: 07/29/24
08/11/23 NCI Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
12/13/23 NCI Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments Link NIH NOSI Application due: 05/08/24
06/17/22 NCI Toward Translation of Nanotechnology Cancer Interventions (TTNCI) (R01 Clinical Trial Not Allowed) Link NIH Application due: 05/17/24
09/15/22 NCI The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed) Link NIH Application due: 06/20/24 LOI due 30 days before application due date
07/27/23 NCI Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments Link NIH NOSI Application due: 05/08/24
12/13/23 NCI Imaging, Biomarkers and Digital Pathomics for the Early Detection of Premetastatic Cancer and Precancerous Lesions Associated with Lethal Phenotypes (R01 Clinical Trial Optional) Link NIH Standard due dates apply
04/01/22 NCI Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
03/11/24 NCI Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required) Link NIH Standard due dates apply
09/18/20 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 -Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
07/11/23 NCI Notice of Special Interest (NOSI): Administrative Supplements for Enhancing Recruitment and Retention of Diverse Populations to Cancer Screening, Cancer Prevention and Symptom Management Clinical Trials Link NIH NOSI Application due: 07/01/25
08/04/22 NCI Academic-Industrial Partnerships for Translation of Technologies for Diagnosis and Treatment (R01 - Clinical Trial Optional) Link NIH Standard due dates apply Earliest due date for new applications is 10/5/22. LOI not required.
10/30/23 NCI Notice of Special Interest (NOSI): Research Projects to Develop Oncoaging Models for Cancer Research Link NIH NOSI Application due: 07/31/27
07/22/22 NCI NCI Mentored Clinical Scientist Research Career Development Award to Promote Diversity (K08 - Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
07/22/22 NCI Advanced Development of Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
07/22/22 NCI NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) Link NIH Application due: 06/12/24
08/02/22 NCI The NCI Transition Career Development Award (K22 - Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/02/22 NCI NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Clinical Trial Required) Link NIH Standard due dates apply
01/17/24 NCI Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences Link NIH NOSI Application due: 05/08/29
06/17/22 NCI Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional) Link NIH Standard due dates apply
12/20/22 NCI National Cancer Institute Program Project Applications for the Years 2023, 2024, and 2025 (P01 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 30 days before application due date
09/18/20 NCI NCI Transition Career Development Award to Promote Diversity (K22 No Independent Clinical Trials) Link NIH Standard due dates apply
10/04/23 NCI Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional) Link NIH Standard due dates apply
10/14/22 NCI Cancer Research Education Grants Program - Research Experiences (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
01/17/24 NCI Notice of Special Interest: National Cancer Institute Supports Applications for the Mentored Research Scientist Development Awards (K01) Within the Mission of the Division of Cancer Control and Population Sciences Link NIH NOSI Application due: 05/08/29
03/31/24 NCI Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk Link NIH NOSI Application due: 05/09/26
10/21/22 NCI Specialized Programs of Research Excellence (SPOREs) in Human Cancers for Years 2021, 2022, 2023 (P50 Clinical Trial Required) Link NIH Standard due dates apply
03/14/23 NCI Notice of Special Interest (NOSI): Disparities Affecting Healthcare Utilization and Health Outcomes Among Childhood Cancer Survivors Link NIH NOSI Application due: 10/09/24
12/11/20 NCI Linking the Provider Recommendation to Adolescent HPV Vaccine Uptake (R21 Clinical Trial Optional) Link NIH Standard due dates apply
08/06/21 NCI Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) Link NIH Standard due dates apply
08/11/23 NCI Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional) Link NIH Standard due dates apply
12/13/23 NCI Notice of Special Interest (NOSI): Electronic Nicotine Delivery Systems (ENDS) and Alternative Nicotine and Tobacco Delivery Systems: Population, Clinical and Applied Prevention Mechanisms of Health Effects Link NIH NOSI Application due: 05/09/24
07/15/22 NCI Notice of Special Interest (NOSI): Research on Interprofessional Teamwork and Coordination During Cancer Diagnosis and Treatment Link NIH NOSI Application due: 10/09/24 First Available Due Date: February 05, 2022, Expiration Date: October 09, 2024
09/15/22 NCI Research Projects in Physical Sciences-Oncology (U01 Clinical Trial Optional) Link NIH Application due: 07/01/24 LOI due 30 days before application due date
05/15/20 NCI Announcement of Availability to Investigators of Lutathera® (815530) For Clinical and Nonclinical Study Proposals Link NCI Lutathera__NSC815530_ Announcement_of_Availability.pdf23.96 KB
10/21/22 NCI Cancer Research Education Grants Program - Curriculum or Methods Development (R25 Clinical Trial Not Allowed) Link NIH Standard due dates apply
08/11/23 NCI Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
12/13/23 NCI Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
04/01/22 NCI Program to Assess the Rigor and Reproducibility of Extracellular Vesicle-Derived Analytes for Cancer Detection (R01 Clinical Trial Not Allowed) Link NIH Standard due dates apply
03/11/24 NCI Notice of Special Interest (NOSI): Administrative supplements to understand effects of within-group heterogeneity on cancer control outcomes in underrepresented populations Link NIH NOSI Application due: 04/30/24
08/02/22 NCI Biology of Bladder Cancer (R21 Clinical Trial Optional) Link NIH Standard due dates apply LOI due 9/16/22 for next application due date of 10/16/22.
07/27/23 NCI Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required) Link NIH Standard due dates apply
11/12/23 NCI Notice of Special Interest (NOSI): Dissemination and Implementation Science for Cancer Prevention and Control in Low Resource Environments Link NIH NOSI Application due: 05/08/24
07/22/22 NCI NCI Transition Career Development Award to Promote Diversity (K22 Independent Clinical Trial Not Allowed) Link NIH Standard due dates apply
07/22/22 NCI Sustained Support for Informatics Technologies for Cancer Research and Management (U24 Clinical Trial Optional) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
03/11/24 NCI Notice of Special Interest (NOSI): Epidemiologic Studies to Assess the Impact of Incretin Mimetics on New and Recurrent Cancer Risk Link NIH NOSI Application due: 05/09/26
06/05/23 NCI Notice of Special Interest (NOSI): Assessing Real-World Effectiveness and Implementation of Telehealth-Guided Provider-to-Provider Communication among Rural Communities Link NIH NOSI Application due: 10/10/26
07/22/22 NCI The NCI Transition Career Development Award (K22 Independent Basic Experimental Studies with Humans Required) Link NIH Standard due dates apply
08/02/22 NCI Utilizing the PLCO Biospecimens Resource to Bridge Gaps in Cancer Etiology and Early Detection Research (U01 Clinical Trial Not Allowed) Link NIH Application due: 06/11/24 LOI due 30 days before application due date
09/10/21 NCI Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed) Link NIH Standard due dates apply Next due date is 10/16/21.
02/04/22 NCI Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed) Link NIH Standard due dates apply Next due date is 6/16/22. LOI not applicable.
12/05/22 NCI Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed) Link NIH Application due: 10/23/24 LOI due 30 days before application due date
04/10/23 NCI Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional) Link NIH Standard due dates apply